Fiche centre
Grand Hôpital de Charleroi
Charleroi — Belgium
Essais liés3clinical trials
VilleCharleroilocalisation
PaysBelgiumlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06757634
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| RCHOP21 | SEP | Phase 3 | NCT01285765 | Evaluate a Treatment Adapted to the PET Response Compared to a Standard Treatment, for Low Risk DLBCL CD 20+ Patients | COMPLETED |
| Arm A: Gedatolisib + Palbociclib + Fulvestrant | Cancer | Phase 3 | NCT06757634 | Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) | RECRUITING |
| LBDGCréfract — Prospective Observational Study of Diffuse Large-cell B Lymphoma | Cancer | À vérifier | NCT06241729 | LBDGCréfract — Prospective Observational Study of Diffuse Large-cell B Lymphoma | RECRUITING |